A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology

被引：7

作者：

Grosman, Benyamin ^{[1
,2
]}

Roy, Anirban ^{[1
]}

Lintereur, Louis ^{[1
]}

Turksoy, Kamuran ^{[1
]}

Benedetti, Andrea ^{[1
]}

Cordero, Toni L. ^{[1
]}

Vigersky, Robert A. ^{[1
]}

Mcvean, Jennifer ^{[1
]}

Rhinehart, Andrew S. ^{[1
]}

Cohen, Ohad ^{[1
]}

机构：

[1] Medtron Diabet, Northridge, CA USA

[2] Medtron Diabet, 18000 Devonshire St, Northridge, CA 91325 USA

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2024年 / 26卷

关键词：

Artificial pancreas; Adaptive control; Type; 1; diabetes; Advanced hybrid closed loop; Automated insulin delivery; Algorithm; LOOP INSULIN DELIVERY; GLUCOSE; SYSTEM;

D O I：

10.1089/dia.2023.0446

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The MiniMed (TM) 780G system (780G) received Conformite Europeenne mark in June 2020 and was, recently, approved by the U.S. Food and Drug Administration (April 2023). Clinical trials and real-world analyses have demonstrated MiniMed (TM) 780G system safety and effectiveness and that glycemic outcomes (i.e., time in range) improve with recommended settings use. In this publication, we will explain the iterative development of the 780G algorithm and how this technology has simplified diabetes management.

引用

页码：17 / 23

页数：7

共 50 条

[21] Is technology worth it? A peek under the hood.
Bays, JP
McCarthy, D
Dunlap, CJ
Feigl, DM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U339 - U339
[22] Predictors of time in target glucose range in real-world users of the MiniMed 780G system
Castaneda, Javier
Mathieu, Chantal
Aanstoot, Henk-Jan
Arrieta, Arcelia
Da Silva, Julien
Shin, John
Cohen, Ohad
DIABETES OBESITY & METABOLISM, 2022, 24 (11): : 2212 - 2221
[23] Glycemic control in pediatric patients of a level ii hospital - life before and after MiniMed 780g™
Albuquerque Costa, A. R.
Monteiro, J.
Vieira da Silva, M.
Laranjo, G.
Campos, J.
HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 285 - 285
[24] GLYCEMIC OUTCOMES OF REAL-WORLD MINIMED™ 780G SYSTEM USERS FROM LATIN AMERICA
Castro, M.
Van Den Heuvel, T.
Arrieta, A.
Castaneda, J.
Grassi, B.
Medina, A. Gomez
Calliari, L. E.
Denise, F.
Raggio, M.
Cohen, O.
DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A108 - A109
[25] Failure of MiniMed 780g to maintain glycemic targets in a type1 diabetic on steroid treatment
Mohana, P.
Bhat, N. K.
HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 253 - 253
[26] CASE REPORT: HYBRID CLOSED LOOP (MEDTRONIC MINIMED 780G) INITIATED DURING A TWIN PREGNANCY
Amigo Farran, J.
Ortiz Zuniga, A.
Sanchez, M.
Ortiz, A. M.
Gil, M.
Hernandez, C.
Simo, R.
Simo, O.
DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A84 - A84
[27] Retrospective observational study on real world use of the Minimed™ 780G automated insulin delivery system: Impact of the settings on autocorrection and omitted meal boluses
Izquierdo, Fidel Jesus Enciso
Garcia, Maria Jose Amaya
Vaquero, Ana Alejandra Cordero
Gamero, Jose Antonio Lucas
Turegano, Paula Gomez-Barrado
Andrada, Maria Luengo
Pearson, Andrea Cordero
Figueredo, Rocio Jazmin Grau
ENDOCRINOLOGIA DIABETES Y NUTRICION, 2024, 71 (06): : 229 - 235
[28] Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users
Da Silva, Julien
Lepore, Giuseppe
Battelino, Tadej
Arrieta, Arcelia
Castaneda, Javier
Grossman, Benyamin
Shin, John
Cohen, Ohad
DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (02) : 113 - 119
[29] Response to: MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias-Response to Inaccurate Allegations
Forlenza, Gregory P.
Sherr, Jennifer L.
DIABETES TECHNOLOGY & THERAPEUTICS, 2024,
[30] SIMPLIFIED MEAL ANNOUNCEMENT VERSUS PRECISE CARBOHYDRATE COUNTING IN ADOLESCENTS WITH TYPE 1 DIABETES USING THE MINIMED 780G ADVANCED HYBRID CLOSED LOOP SYSTEM
Petrovski, G.
Campbell, J.
Pasha, M.
Van Den Heuvel, T.
DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A126 - A126

← 1 2 3 4 5 →